Recursion Pharmaceuticals (RXRX) shares recently closed at US$3.98, with the stock showing a negative return over the past month and past 3 months, which may prompt investors to reassess its current ...

A few stanzas from the end of Chaucer’s long poem “Troilus and Criseyde,” the author interrupts his story to indulge in a bit of reception anxiety. “Go, litel book,” he bids the manuscript that’s soon ...

Earlier in January, Recursion Pharmaceuticals updated investors at the JP Morgan Healthcare Conference on its AI-powered drug discovery platform, clinical programs, and collaborations with partners ...

SAN FRANCISCO -- One new startup is called Recursive with an "e." Another is called Ricursive with an "i." They are trying to do the same thing: Build artificial intelligence that can improve itself ...

A look behind the scenes of the star’s second album turns out to reveal exactly what you’d expect, at arduous length Paris Hilton here presents us with an unbearable act of docu-self-love, avowedly a ...

The funding discussions highlight ongoing investor demand for new and unproven research labs looking to find novel approaches to AI that push the technology forward. Recursive’s goal is to develop ...

Java Development Kit (JDK) 26, a planned update to standard Java due March 17, 2026, has reached the initial release candidate (RC) stage. The RC is open for critical bug fixes, with the feature set ...

Thirty years ago, living in Cambridge, England, I wandered into Heffers Bookshop and picked up a monstrous new novel on the display table. It had a title out of Hamlet, a Simpsons-sky dustjacket, ...

This essay and interview appear in this week’s The Book Pages newsletter. For more information and book coverage, sign up for the free newsletter. Years ago, I taught English as a Second Language at a ...